Evotec
Shiju Mathew FCCA is an experienced Financial Reporting Manager at Evotec, with a background in various financial roles at companies such as twogether-Next15, Shepherd, Opus Energy, and RPS Europe. With a strong foundation in accounting and finance from Oxford Brookes University and ACCA, Shiju has expertise in financial reporting, stakeholder management, budgeting, financial analysis, and process optimization. Their experience includes overseeing AR & AP, business partnering, internal control processes, and leading and motivating finance teams. In addition, Shiju has a track record of implementing processes, improving internal controls, and ensuring compliance with regulatory requirements.
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.